An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms

Movement Disorders

Volumn 25, Issue 16, 2010, Pages 2728-2734

  Arabia, Gennarina ^a   Morelli, Maurizio ^a   Paglionico, Sandra ^a   Novellino, Fabiana ^a   Salsone, Maria ^a   Giofrè, Laura ^a   Torchia, Giusi ^b   Nicoletti, Giuseppe ^b   Messina, Demetrio ^b   Condino, Francesca ^b   Lanza, Pierluigi ^b   Gallo, Olivier ^b   Quattrone, Aldo ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Atypical parkinsonian syndromes; Neuroimaging; Parkinson's disease

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRARATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; PUTAMEN; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 78650182604     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23173     Document Type: Article

References (25)

1. Ke Y, Qian ZM. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003; 2: 246-253.
2. Moos T, Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci 2004; 1012: 14-26.
3. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004; 5: 863-873.
4. Ye FQ, Allen PS, Martin WR. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 1996; 11: 243-249.
5. Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989; 39: 1524-1526.
6. Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multiple system atrophy. Radiology 1990; 174: 693-696.
7. Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin 1992; 10: 405-420.
8. Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986; 159: 493-498.
9. Pastakia B, Polinsky R, Di Chiro G, Simmons JT, Brown R, Wener L. Multiple system atrophy (Shy-Drager sindrome): MR imaging. Radiology 1986; 159: 499-502.
10. Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998; 65: 65-71.
11. Seppi K, Schocke MF, Mair KJ, et al. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 2006; 31: 240-245.
12. O'brien C, Sung JH, Mcgeachie RE, Lee MC. Striatonigral degeneration: clinical MRI and pathologic correlation. Neurology 1990; 40: 710-711.
13. Lang AE, Curran T, Provias J, Bergeron C. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Can J Neurol Sci 1994; 21: 311-318.
14. Schwarz J, Weis S, Kraft E, et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996; 60: 98-101.
15. Macia F, Yekhlef F, Ballan G, Delmer O, Tison F. T2-hyperintense lateral rim and hypointense putamen are typical but not exclusive of multiple system atrophy. Arch Neurol 2001; 58: 1024-1026.
16. Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002; 59: 835-842.
17. Kraft E, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002; 59: 1265-1267.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
19. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
20. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163: 94-98.
21. Righini A, Antonini A, Ferrarini M, et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr 2002; 26: 266-271.
22. Milton WJ, Atlas SW, Lexa FJ, Mozley PD, Gur RE. Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. Radiology 1991; 181: 715-719.
23. Von Lewinski F, Werner C, Jörn T, Mohr A, Sixel-Döring F, Trenkwalder C. T2*-weighted MRI in diagnosis of multiple system atrophy-a practical approach for clinicians. J Neurol 2007; 254: 1184-1188.
24. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005; 23: 1-25.
25. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008; 70: 1411-1417.